Distinctions between non-peptide angiotensin II AT1-receptor antagonists
A far-reaching understanding of the molecular action mechanism of AT1-receptor antagonists (AIIAs) was obtained by using CHO cells expressing transfected human AT 1-receptors. In this model, direct [3H]-antagonist binding and inhibition of agonist-induced responses (inositol phosphate accumulation)...
Main Authors: | Georges Vauquelin, Frederik LP Fierens, Ilse Verheijen, Patrick ML Vanderheyden |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2001-03-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/14703203010020010401 |
Similar Items
-
Binding characteristics of [3H]-irbesartan to human recombinant angiotensin type 1 receptors
by: Patrick ML Vanderheyden, et al.
Published: (2000-06-01) -
Role of basic amino acids of the human angiotensin type 1 receptor in the binding of the non-peptide antagonist candesartan
by: Georges Vauquelin, et al.
Published: (2001-03-01) -
Lys 199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists
by: Frederik LP Fierens, et al.
Published: (2000-09-01) -
Cellular targets for angiotensin II fragments: pharmacological and molecular evidence
by: Georges Vauquelin, et al.
Published: (2002-12-01) -
ANGIOTENSIN II RECEPTOR ANTAGONISTS AND PROTEINURIA
by: Tanja Kök, et al.
Published: (2002-03-01)